Jump Financial, LLC Bio Atla, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$2.3 - $8.25 $107,639 - $386,100	46,800 New	46,800 $125,000
Q2 2022 Aug 09, 2022	SELL	$2.13 - $5.38 $53,463 - $135,038	-25,100 Reduced 61.98%	15,400 $44,000
Q1 2022 May 12, 2022	BUY	$4.38 - $18.78 $57,378 - $246,018	13,100 Added 47.81%	40,500 $203,000
Q4 2021 Feb 10, 2022	BUY	$19.0 - $30.95 $25,270 - $41,163	1,330 Added 5.1%	27,400 $538,000
Q3 2021 Nov 12, 2021	BUY	$29.44 - $43.74 $426,438 - $633,573	14,485 Added 125.03%	26,070 $767,000

Q2 2021 Aug 13, 2021	BUY	$38.07 - $56.17 $441,040 - $650,729	11,585 New	11,585 $491,000

24.8M

140K

4.6K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $47.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.